Ever increasing number of the animal model systems for attention deficit/hyperactivity disorder: Attention, please

Biomolecules and Therapeutics

Volumn 16, Issue 4, 2008, Pages 312-319

  Kim, Hee Jin ^a   Park, Seung Hwa ^b   Kim, Kyeong Man ^c   Ryu, Jong Hoon ^d   Cheong, Jae Hoon ^a   Shin, Chan Young ^b  

^a Sahmyook University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Chonnam National University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Acquired animal models; Genetic models; Hyperactivity; Impusivity; Inattention

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; LEAD; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROTOXIN; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; OXIDOPAMINE; PHENYLALANINE; POLYCHLORINATED BIPHENYL; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROTROPIN;

ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; C57BL 6 MOUSE; CELL MIGRATION; CEREBELLUM INJURY; CLINICAL FEATURE; GENETIC VARIABILITY; HYPERACTIVITY; IMPULSIVENESS; KNOCKOUT MOUSE; LEAD POISONING; LONG EVANS CINNAMON RAT; MAZE TEST; MESENCEPHALON; MUTANT; NEUROFIBROMATOSIS; NEWBORN HYPOXIA; NONHUMAN; PHENYLKETONURIA; PRENATAL EXPOSURE; PROTEIN EXPRESSION; RISK FACTOR; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; SOCIAL ISOLATION; SPONTANEOUSLY HYPERTENSIVE RAT; SYNAPTIC MEMBRANE; THYROID HORMONE BLOOD LEVEL; WISTAR KYOTO RAT;

ANIMALIA;

EID: 69549138033     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.4.312     Document Type: Article

References (52)

1. Adams, W., Kusljic, S. and van den Buuse, M. (2008). Serotonin depletion in the dorsal and ventral hippocampus: Effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology. doi:10.1016/j.neuropharm. 2008.06.035.
2. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol. Bull. 121, 65-94.
3. Bruno, K. J., Freet, C. S., Twining, R. C., Egami, K., Grigson, P. S. and Hess, E. J. (2006). Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD. Neurobiol. Dis. 25, 206-216.
4. Burd, L., Klug, M. G., Coumbe, M. J. and Kerbeshian, J. (2003). Children and adolescents with attention deficit-hyperactivity disorder. 1. Prevalence and cost of care. J. Child. Neurol. 18, 555-561. (Pubitemid 37098632)
5. Casolini, P., Zuena, A. R., Cinque, C., Matteucci, P., Alema, G. S., Adriani, W., Carpinelli, G., Santoro, F., Alleva, E., Bosco, P., Nicoletti, F., Laviola, G. and Catalani, A. (2005). Sub-neurotoxic neonatal anoxia induces subtle behavioural changes and specific abnormalities in brain group-I metabotropic glutamate receptors in rats. J. Neurochem. 95, 137-145. (Pubitemid 41384432)
6. Cheon, K. A., Ryu, Y. H., Kim, Y. K., Namkoong, K., Kim, C. H. and Lee, J. D. (2003). Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur. J. Nucl. Med. 30, 306-311. (Pubitemid 36686852)
7. Chess, A. C., Keene, C. S., Wyzik, E. C. and Bucci, D. J. (2005). Stimulus processing and associative learning in Wistar and WKHA rats. Behav. Neurosci. 119, 772-780.
8. Dalley, J. W., Theobald, D. E., Pereira, E. A., Li, P. M. and Robbins, T. W. (2002). Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioral performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl). 164, 329-340.
9. Davids, E., Zhang, K., Kula, N. S., Tarazi, F. I. and Baldessarini, R. J. (2002). Effects of norepinephrine and serotonin transporterer inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J. Pharmacol. Exp. Ther. 301, 1097-1102. (Pubitemid 34595102)
10. Dell'Anna, M. E. (1999). Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behav. Brain. Res. 45, 125-134.
11. Ferguson, S. A. (2001). A review of rodent models of ADHD. In: Solano, M. V., Arnsten, A. F. T. and Castellanos, F. X. (eds) Stimulant Drugs adnd ADHD, Basic and Clinical Neuroscience. University Press, Oxford. pp 209-220.
12. Ferguson, S. A., Paule, M. G. and Holson, R. R. (1996). Functional effects of ethylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol. Teratol. 18, 529-537. (Pubitemid 26346098)
13. Gainetdinov, R. R., Jones, S. R. and Caron, M. G. (1999). Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol. Psychiatr. 46, 303-311. (Pubitemid 29335911)
14. Glaser, P. E., Surgener, S. P., Grondin, R., Gash, C. R., Palmer, M., Castellanos, F. X. and Gerhardt, G. A. (2006). Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis? J. Neurosci. Methods. 151, 62-67. (Pubitemid 43233702)
15. Greco, B. and Carli, M. (2006). Reduced attention and increased impulsivity in mice lacking NPY Y2 receptors: relation to anxiolytic-like phenotype. Behav. Brain. Res. 169, 325-334.
16. Hausknecht, K. A., Acheson, A., Farrar, A. M., Kieres, A. K., Shen, R. Y., Richards, J. B. and Sabol, K. E. (2005). Prenatal alcohol exposure causes attention deficits in male rats. Behav. Neurosci. 119, 302-310. (Pubitemid 40279519)
17. Hendley, E. D. and Ohlsson, W. G. (1991). Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive rats. Am. J. Physiol. (Heart Circ Physiol). 261, H583-H589.
18. Highfield, D. A., Hu, D. and Amsel, A. (1998). Alleviation of x-irradiation- based deficit in memory-based learning by D-amphetamine: Suggestions for attention deficit/ hyperactivity disorder. Proc. Natl. Acad. Sci. USA. 95, 5785-5788.
19. Hirano, M., Rakwal, R., Shibato, J., Sawa, H., Nagashima, K., Ogawa, Y., Yoshida, Y., Iwahashi, H., Niki, E. and Masuo, Y. (2008). Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research. J. Proteome. Res. 7, 2471-2489.
20. Holson, R. R., Gazzara, R. A., Ferguson, S. A. and Adams, J. (1997). Behavioral effects of low-dose gestational day 11-13 retinoic acid exposure. Neurotoxicol. Teratol. 19, 355-362.
21. Hunziker, M. H., Saldana, R. L. and Neuringer, A. (1996). Behavioral variability in SHR and WKY rats as a function of rearing environment and reinforcement contingency. J. Exp. Anal. Behav. 65, 129-144.
22. Kamimura, E., Ueno, Y., Tanaka, S., Sawa, H., Yoshioka, M., Ueno, K. I., Inoue, T., Li, X., Koyama, T., Ishikawa, R. and Nagashima, K. (2001). New rat model for attention deficit hyperactive disorder (ADHD). Comp. Med. 51, 245-251. (Pubitemid 32661989)
23. Kayl, A. E., Moore, B. D. 3rd., Slopis, J. M., Jackson, E. F. and Leeds, N. E. (2000). Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J. Child. Neurol. 15, 90-96.
24. Kohlert, J. G. and Bloch, G. J. (1993). A rat model for attention deficit-hyperactivity disorder. Physiol. Behav. 53, 1215-1218.
25. Kimura-Kuroda, J., Nagata, I. and Kuroda, Y. (2007). Disrupting effects of hydroxy-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: a possible causal factor for developmental brain disorders? Chemosphere 67, S412-S420.
26. Kostrzewa, R. M., Brus, R., Kalbfleisch, J. H., Perry, K. W. and Fuller, R. W. (1994). Proposed animal model of attention deficit hyperactivity disorder. Brain Res. Bull. 34, 161-167. (Pubitemid 24125414)
27. Leo, D., Sorrentino, E., Volpicelli, F., Eyman, M., Greco, D., Viggiano, D., di. P. U. and Perrone-Capano, C. (2003). Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci. Biobehav. Rev. 27, 661-669. (Pubitemid 37414914)
28. Li, W., Cui, Y., Kushner, S. A., Brown, R. A., Jentsch, J. D., Frankland, P. W., Cannon, T. D. and Silva, A. J. (2005). The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr. Biol. 15, 1961-1967. (Pubitemid 41566145)
29. Magara, F., Ricceri, L., Wolfer, D. P. and Lipp, H. P. (2000). The acallosal mouse strain I/LnJ: A putative model of ADHD? Neurosci. Biobehav. Rev. 24, 45-50. (Pubitemid 30026146)
30. Mandolesi, L., Leggio, M. G., Spirito, F., Federico, F. and Petrosini, L. (2007). Is the cerebellum involved in the visuolocomotor associative learning? Behav. Brain. Res. 184, 47-56. (Pubitemid 47404651)
31. Mill, J., Curran, S., Kent, L., Gould, A., Huckett, L., Richards, S., Taylor, E. and Asherson, P. (2002). Association study of a SNAP-25 microsatellite and attention deficit hyperactivity disorder. Am. J. Med. Genet. 114, 269-271. (Pubitemid 34258849)
32. Molina-Holgado, E., Dewar, K., Descarries, L. and Reader, T. A. (1994). Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270, 713-721.
33. Mostofsky, S. H., Reiss, A. L., Lockhart, P. and Denckla, M. B. (1998). Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J. Child. Neurol. 13, 434-439.
34. Nigg, J. T. (2008). ADHD, lead exposure and prevention: how much lead or how much evidence is needed? Expert. Rev. Neurother. 8, 519-521.
35. Oorschot, D. E., Voss, L., Covey, M. V., Bilkey, D. K. and Saunders, S. E. (2007). ADHD-like hyperactivity, with no attention deficit, in adult rats after repeated hypoxia during the equivalent of extreme prematurity. J. Neurosci. Methods 166, 315-322. (Pubitemid 350016393)
36. Pattij, T. and Vanderschuren, L. J. (2008). The neuropharmacology of impulsive behaviour. Trends Pharmacol. Sci. 29, 192-199.
37. Russell, V. A., Sagvolden, T. and Johansen, E. B. A. (2005). Animal models of attention-deficit hyperactivity disorder. Behav. Brain Funct. 1, 9. (Pubitemid 44848786)
38. Sagvolden, T. (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24, 31-39. (Pubitemid 30026144)
39. Sarkissian, C. N., Boulais, D. M., McDonald, J. D. and Scriver, C. R. (2000). A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia. Mol. Genet. Metabol. 69, 188-194. (Pubitemid 30241684)
40. Shaywitz, B. A., Yager, R. D., Klopper, J. H. (1976). Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191, 305-308.
41. Siesser, W. B., Zhao, J., Miller, L. R., Cheng, S. Y. and McDonald, M. P. (2006). Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes. Brain Behav. 5, 282-297.
42. Taylor, E. (1998). Clinical foundations of hyperactivity research. Behav. Brain Res. 94, 11-24.
43. Trinh J. V, Nehrenberg D. L, Jacobsen J. P, Caron M. G. and Wetsel W. C. (2003) Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice. Neuroscience 118, 297-310.
44. Tsai, S. J. (2007). Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med. Hypotheses 68, 896-899.
45. Ueno, K., Togashi, H., Matsumoto, M,, Ohashi, S., Saito, H. and Yoshioka, M. (2002). Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J. Pharmacol. Exp. Ther. 302, 95-100.
46. Ujhzy, E., Schmidtov, M., Dubovick, M., Navarova, J., Brucknerov, I. and Mach, M. (2006). Neurobehavioural changes in rats after neonatal anoxia: effect of antioxidant stobadine pretreatment. Neuro. Endocrinol. Lett. 27 Suppl 2, 82-85. (Pubitemid 46534344)
47. van den Bergh, F. S., Bloemarts, E., Chan, J. S., Groenink, L., Olivier, B. and Oosting, R. S. (2006). Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. Pharmacol. Biochem. Behav. 83, 380-390. (Pubitemid 43736958)
48. Viggiano, D., Vallone, D., Welzl, H. and Sadile, A. G. (2002). The Naples High- and Low-Excitability rats: Selective breeding, behavioral profile, morphometry, and molecular biology of the mesocortical dopamine system. Behav. Genet. 32, 315-333. (Pubitemid 35192993)
49. Winstanley, C. A., Dalley, J. W., Theobald, D. E. and Robbins, T. W. (2003). Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl). 170, 320-331.
50. Watanabe, Y., Fujita, M., Ito, Y., Okada, T., Kusuoka, H. and Nishimura, T. (1997). Brain dopamine transporter in spontaneously hypertensive rats. J. Nucl. Med. 38, 470-474. (Pubitemid 27376906)
51. Zang, Y. F., He, Y., Zhu, C. Z., Cao, Q. J., Suim M. Q., Liang, M., Tian, L. X., Jiang, T. Z. and Wang, Y. F. (2007). Altered baseline brain activity in children with ADHD revealed by resting- state functional MRI. Brain. Dev. 29, 83-91.
52. Zhang, K., Davids, E., Tarazi, F. I. and Baldessarini, R. J. (2002). Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl) 161, 100-106. (Pubitemid 34437975)